EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum

Yusuke Hashimoto iD, Duc Trung Dao, Ikuro Kasuga, Taichiro Takemura, Haruka Abe, Futoshi Hasebe, Takahiro Nomura, Jun Kurushima iD, Hidetada Hirakawa iD, Koichi Tanimoto, Pham Duy Thai, Hoang Huy Tran und 3 weitere

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01168-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Yusuke Hashimoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan. Hauptthemen laut MEDLINE: Linezolid, Plasmids, Anti-Bacterial Agents, Vancomycin Resistance. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology, Environmental Restoration and Conservation Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vancomycin and linezolid are crucial for treating enterococcal infections. The global emergence of linezolid- and vancomycin-resistant enterococci is a growing concern. Enterococcal pELF-type linear plasmids, which confer both types of resistance, have been identified worldwide from clinical and environmental sources. Phylogenetic and structural analyses of pELF-type linear plasmids revealed that they diverged into two distinct lineages and evolved through the integration of circular plasmids. Our findings on this ongoing evolution advance the fundamental knowledge required for the future development of global and cross-sectoral surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidPlasmidsAnti-Bacterial AgentsVancomycin ResistanceVancomycin-Resistant EnterococciVancomycinMicrobial Sensitivity TestsHumansPhylogenyEnterococcus faeciumEvolution, Molecular

Stichwörter der Autor:innen

Enterococcus faeciumTn6674-like transposonlinezolid resistancepELF-type linear plasmidsvancomycin resistance

Substanzen

LinezolidAnti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Department of Bacteriology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Department of Bacteriology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Research Center for Advanced Science and Technology, The University of Tokyo, Meguro-ku, Tokyo, Japan.
  • Department of Urban Engineering, Graduate School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Institute of Tropical Medicine, Nagasaki University, Nagasaki, Nagasaki, Japan.
  • Laboratory of Bacterial Drug Resistance, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

ORCID-Profile: Yusuke Hashimoto, Jun Kurushima, Hidetada Hirakawa, Masato Suzuki, Haruyoshi Tomita

Förderung

  • Japan Agency for Medical Research and Development
  • Ministry of Education, Culture, Sports, Science and Technology
  • Environmental Restoration and Conservation Agency
  • Gunma Foundation for Medicine and Health Science
  • Japanese Ministry of Health, Labor and Welfare
  • Takeda Science Foundation
  • Astellas Foundation for Research on Metabolic Disorders
  • Ohsumi Frontier Science Foundation (OFSF)

Zitieren

APA

Hashimoto, Y., Dao, D. T., Kasuga, I., Takemura, T., Abe, H., Hasebe, F., Nomura, T., Kurushima, J., Hirakawa, H., Tanimoto, K., Thai, P. D., Huy Tran, H., Shibayama, K., Suzuki, M., & Tomita, H. (2025). Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01168-25

Vancouver

Hashimoto Y, Dao DT, Kasuga I, Takemura T, Abe H, Hasebe F, et al. Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01168-25

BibTeX
@article{Hashimoto2025,
  author = {Hashimoto, Yusuke and Dao, Duc Trung and Kasuga, Ikuro and Takemura, Taichiro and Abe, Haruka and Hasebe, Futoshi and Nomura, Takahiro and Kurushima, Jun and Hirakawa, Hidetada and Tanimoto, Koichi and Thai, Pham Duy and Huy Tran, Hoang and Shibayama, Keigo and Suzuki, Masato and Tomita, Haruyoshi},
  title = {Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01168-25}
}
Kostenlos starten →